Assessment of a primary care-based telemonitoring intervention for home care patients with heart failure and chronic lung disease. The TELBIL study by Martín-Lesende, Iñaki et al.
STUDY PROTOCOL Open Access
Assessment of a primary care-based telemonitoring
intervention for home care patients with heart
failure and chronic lung disease. The TELBIL study
Iñaki Martín-Lesende
1, Estibalitz Orruño
2*, Carmen Cairo
1, Amaia Bilbao
3, José Asua
4, María I Romo
1, Itziar Vergara
3,
Juan C Bayón
2, Roberto Abad
1, Eva Reviriego
2, Jesús Larrañaga
1
Abstract
Background: Telemonitoring technology offers one of the most promising alternatives for the provision of health
care services at the patient’s home. The primary aim of this study is to evaluate the impact of a primary care-based
telemonitoring intervention on the frequency of hospital admissions.
Methods/design: A primary care-based randomised controlled trial will be carried out to assess the impact of a
telemonitoring intervention aimed at home care patients with heart failure (HF) and/or chronic lung disease (CLD).
The results will be compared with those obtained with standard health care practice. The duration of the study will
be of one year. Sixty patients will be recruited for the study. In-home patients, diagnosed with HF and/or CLD,
aged 14 or above and with two or more hospital admissions in the previous year will be eligible.
For the intervention group, telemonitoring will consist of daily patient self-measurements of respiratory-rate, heart-
rate, blood pressure, oxygen saturation, weight and body temperature. Additionally, the patients will complete a
qualitative symptom questionnaire daily using the telemonitoring system. Routine telephone contacts will be
conducted every fortnight and additional telephone contacts will be carried out if the data received at the primary
care centre are out of the established limits. The control group will receive usual care. The primary outcome
measure is the number of hospital admissions due to any cause that occurred in a period of 12 months post-
randomisation. The secondary outcome measures are: duration of hospital stay, hospital admissions due to HF or
CLD, mortality rate, use of health care resources, quality of life, cost-effectiveness, compliance and patient and
health care professional satisfaction with the new technology.
Discussion: The results of this study will shed some light on the effects of telemonitoring for the follow-up and
management of chronic patients from a primary care setting. The study may contribute to enhance the
understanding of alternative modes of health care provision for medically unstable elderly patients, who bear a
high degree of physical and functional deterioration.
Trial Registration: ISRCTN: ISRCTN89041993
Background
It is estimated that by 2020, chronic diseases will contri-
bute to more than 60% of illnesses requiring treatment
[1]. Frequently, several chronic diseases occur at the
same time in the same patients, often elderly individuals.
This patient group, progressively growing in size, is
characterised by a high use of health care resources, ele-
vated rates of hospitalisations and a high prevalence of
disability and dependence during the course of the dis-
ease [1-4]. Elderly chronic patients frequently experience
multiple hospital admissions and such exacerbations
have a major impact on the quality of life. There is good
evidence that early identification of the exacerbations
t h a ta r i s ef r o mh e a r tf a i l u r e( H F )a n dc h r o n i cl u n gd i s -
ease (CLD) reduces the risk for hospital admission and
improves the quality of life of these chronic patients [5,6].
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impact of chronic diseases, there is a pressing need to
adapt and to search for new approaches to health care.
In this sense, the used of information and communica-
tion technology (ICT) applied to the monitoring of
chronic patients provides new health care alternatives.
Thus, novel methods for the delivery of quality health
care could increase the effectiveness of chronic disease
management while containing costs and using scarce
human resources to maximum effect. Home telemoni-
toring allows the transmission of patients’ vital signs
once or more per day and provides diagnostic informa-
tion to health care professionals. Telemetric-supported
self-monitoring of HF and CLD has the potential to pro-
mote self-care, improve compliance, enable timely
response to deterioration and improve the follow-up
after hospital discharge [7,8]. A number of studies have
shown that telemonitoring improves the quality of life
of patients and their families [9,10]. From an economic
view point, home telemonitoring of chronic patients
appears to reduce health care costs [11-14]. Neverthe-
less, higher-quality economic studies are required to
give greater insights into the potential cost-effectiveness
of home telemonitoring [15].
Home telemonitoring has been found to reduce rates of
hospitalisation and emergency department visits for
chronic obstructive pulmonary disease (COPD) patients,
while findings for hospital bed days were not consistent
and varied between studies [15,16]. There was a higher
mortality-rate among patients with COPD using home
telemonitoring compared with usual care, but the num-
ber of original studies was scarce and the sample sizes
were relatively small. Hence, the outcomes must be inter-
preted cautiously [15,16]. According to recent systematic
reviews, telemonitoring interventions for patients with
HF have been shown to be effective in reducing the risk
of all-cause mortality, HF-related hospitalisations and
emergency department visits [15,17-19]. Moreover, the
use of home telemonitoring for patients with HF
improved quality of life, patient self-care and evidence-
based prescribing [15,17-19]. However, further studies of
high methodological quality are required to give more
precise information about the potential clinical benefits
of home telehealth interventions prior to scaling-up the
use of the new technology [7,19].
The telemonitoring system used in the present study is
based on a telemonitoring system employed in another
hospital-based clinical trial[ 2 0 ] .T h eh o m et e l e m o n i t o r -
ing system has been successfully tested on patients with
HF and COPD in a randomised controlled trial carried
out in Donostia University Hospital (Basque Country),
Current Controlled Trials ISRCTN62033748. In contrast
to the aforementioned trial, in the present study the man-
agement of the telemonitoring intervention is carried out
b yp r i m a r yc a r en u r s e sa n dg e neral practitioners (GPs).
To the best of our knowledge, no other primary care-
based tele-homecare studies have been undertaken with
regards to the type of patients and the telemonitoring
procedure employed in this investigation.
Hypothesis and objectives of the study
The hypothesis that we set out to test in this study is
that telemonitoring controlled by a primary care team
can benefit home care patients with HF and/or CLD,
and thereby, reduce the number of hospital admissions.
We also postulate that home telemonitoring may
improve the quality of life of these patients in a way
that is cost-effective and acceptable to both, patients
and health care professionals.
The main objective of the study is to evaluate the
impact of a primary care-based telemonitoring interven-
tion on the use of health care resources, specifically on
the frequency of hospital admissions.
The secondary objectives are:
1. To analyse the impact of the intervention on mor-
tality, duration of hospital stay, use of emergency ser-
vices, visits to primary care physicians and to specialists,
home visits, and telephone calls.
2. To evaluate the telemonitoring procedure in eco-
nomic terms compared to usual care through a cost-
effectiveness analysis. The impact on the quality of life
of the participating patients will also be assessed.
3. To assess the degree of satisfaction of the patients/
caregivers and health care professionals with the telemo-
nitoring intervention.
Methods/design
Main characteristics of the study
Study design
This is a randomised controlled trial with a one-year fol-
low-up. In the intervention group (IG), in addition to the
standard practice, patients will be monitored using a tele-
monitoring procedure, while the control group (CG) will
receive the usual care. Participants will gradually join the
study over a period of six months. The recruitment per-
iod could be extended to reach the targeted number of
patients. Interim data analysis will be carried out after 3
and 6 months of follow-up and the final results will be
obtained at 12 months post-randomisation. Figure 1 out-
lines the general study design.
Study area
This study is being carried out across 23 health centres
of the Bilbao Primary Care Health Region (Basque
Country, Spain). The Health Region serves a catchment
population of 390,000 people, of whom around 27% are
over 60 years old. The team of professionals in charge
of the first level of health care is composed of 218 GPs,
269 nurses and 44 paediatricians. At the hospital level,
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the main hospital in the area, and Santa Marina Hospi-
tal, which is primarily focused on chronic diseases and
palliative care.
Intervention
Description of the intervention
In the IG, telemonitoring will consist of daily transfers of
the following self-measured clinical parameters: respira-
tory-rate, heart-rate, blood pressure, blood oxygen
saturation using pulse oxymetry, weight and body tem-
perature. Together with the clinical data, patients will
also complete a brief questionnaire aimed at assessing
the patient’s perception of his/her medical and functional
condition. The questionnaire also contains items con-
cerning compliance with medication and diet. Health
professionals will check the data daily and will routinely
contact the patient by phone every two weeks (nursing
staff). Other telephone contacts will be carried out, if
necessary, if the data received at the primary health care
centre are out of the established limits. The telemonitor-
ing system comprises personalised alerts set for each
patient, with messages being sent to a Web-based plat-
form when the recorded parameters fall outside estab-
lished limits (which may be adjusted over time).
We have established standard initial threshold values
for all the telemonitored parameters, which can be
further modified by health care professionals according




RANDOMISATION 1:1 
Stratification by disease 
In-home patients with HF or CHRONIC LUNG DISEASE,  
 2 hospital admissions (at least 1 due to the above mentioned diseases) 
in the previous year 
N = 240 patients 
Intervention Group (IG) 
Home telemonitoring  
N = 30 
Control Group (CG) 
Usual Care 
N = 30 
Assessed 
n 
Assessed 
n 
Baseline 
characteristics 
Homogeneity 
Health care 
professional 
satisfaction 
 
Partial results 
Patient/caregiver 
satisfaction  
 
Partial results 
1-YEAR ANALYSIS 
3 months 
6 months 
Deaths 
& other losses 
Deaths 
& other losses 
Excluded: 
In residential care 
Frequent hospital treatment 
In terminal phase 
Cognitive impairment 
Unwilling to participate 
Compliance with 
telemonitoring 
Figure 1 General design of the randomised controlled trial.
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lished threshold values are essential for the monitoring
of the patient’s condition and for the detection of unu-
sual changes. When the measurements fall outside the
established limits, alerts will be triggered via the PDA
terminal and the clinical staff will act according to the
medical condition of the patient. Alternatively, the
patients will be advised to call the emergency services at
the weekends and at times when the health centres are
closed.
The standard threshold values for alerts are shown in
Table 1.
In the CG, patients will receive usual care, consisting
of regular medical examinations in line with the estab-
lished programmes for monitoring home-based patients.
The frequency of the medical examinations will vary
depending on the clinical, social and family situation of
each patient. Additionally, the GP and/or nurse will see
or call the patient on demand in the event of a dete-
rioration in the medical condition. Note that the IG will
receive usual care, as well as the extra telemonitoring
specified under the study protocol.
Prior to the intervention, all GPs and nurses in charge
of the care of the participating patients (in both IG and
CG) will attend a 4-hour workshop on the management
of HF and COPD and early detection of relapses. Addi-
tionally, the health care professionals involved with the
IG will receive further training on the use of the telemo-
nitoring system. The key activities for the CG and IG
are outlined in Figure 2.
Technical features of the system and devices for data
transfer and reception
The telemonitoring equipment, supplied by Saludnova
[20], consists of a touch screen PDA which runs the
Microsoft’s Windows Mobile operating system, with
wireless Bluetooth sensors to measure blood pressure,
heart-rate and oxygen saturation, and manual input of
body temperature, respiratory-rate, weight, question-
naires on the medical condition, any perceived changes
and a record of compliance with medication and diet.
The telemonitoring kit used by patients in the interven-
tion group is shown in Figure 3. The data will be trans-
ferred via GPRS to the Web-based platform (Web data
manager). The centralised Web management system
allows different levels of access depending on the speci-
fic roles of the participating professionals (project
leaders, GPs/nurses, hospital). The screen of the Web-
platform accessed by health care professionals to check
the transmitted data is shown in Figure 4. Although the
platform can be accessed from any computer connected
to the internet, it should be noted that there are term-
inals available in the consultation rooms of the health
centres and in one of the referral hospitals (Santa Mar-
ina Hospital), which given its characteristics, often pro-
vides care to this type of patients.
Study Population
Eligible patients
The patients included in the study are all attached to
the health centres of the Bilbao Primary Health Care
Region, are under home care (i.e.: in-home patients that
receive routine health care at home due to lack of or
severe difficulties with mobility), aged 14 or above, have
been diagnosed with HF and/or CLD, with two or more
hospital admissions during the previous year and at
least one of these admissions having been associated
with one of the two conditions under study.
Exclusion criteria
The following patients are excluded from the study:
those in residential care under the supervision of speci-
fic health care professionals, those receiving regular
monitoring or treatment by specialists or hospital ser-
vices (such as, rehabilitation programmes, haemodialysis,
care in hospital day-care centres, etc.), those in the
terminal phases (with a life expectancy under 6 months)
of other illnesses (not HF or CLD), patients with cogni-
tive impairment and those not willing to participate in
the study.
Patient selection process
The lists of patients with two or more hospital admissions
for any cause between the 1
st of December 2008 and the
1
st of December 2009 (12,293 people) was obtained from
the hospital records of the two referral hospitals of the
Health Region. Subsequently, 240 in-home patients suffer-
ing from the clinical conditions under investigation (i.e.:
HF and/or CLD) were identified using the primary care
medical record database (“Osabide”) .F i f t yn i n eo ft h e s e
home care patients met all the inclusion criteria and
Table 1 Established thresholds for the telemonitored
parameters
Telemonitored
parameters
Established threshold values
Respiratory-rate < 12 or >24 breaths per minute (bpm)
Heart-rate < 50 or >100 beats per minute (bpm)
Systolic blood
pressure
< 100 or >160 millimeters of mercury (mmHg)
Diastolic blood
pressure,
< 60 or >95 millimeters of mercury (mmHg)
Oxygen saturation < 95% (this is a frequently adjusted limit for
patients with CLD)
Temperature > 37°C
Weight Should be notified if there is an increase of 1 Kg
in three days
Qualitative
questionnaire
Negative answers to the questionnaire which
correspond to: feeling worse, breathing
difficulties, increased nocturia, oedema, worsening
of cough, increased sputum production and a
change in sputum colour
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for the first phase of the recruitment process. One of the
limiting inclusion criterion applied was the fact that at
least one of the hospital admissions had to be due to HF
or CLD. Progressively, inclusion of additional patients will
also be sought through meetings held in the health cen-
tres, until the pre-established number of patients is
reached.
Randomisation
We used a stratified random sampling by disease (HF,
CLD or both), which consisted of the random selection
of patients for allocation to the control and intervention
groups from three containers holding the codes of the
initial patients. Subsequent draws were made to main-
tain the 1:1 ratio between the two study groups and
between the three different strata considered.
Recruitment of patients
After GPs and nurses from the 23 health centres agreed
to join the study, eligible patients were provided with
information about the study and were invited to partici-
pate and sign a written informed consent form. Addi-
tionally, the patients from the IG were given a “Patient
information sheet” with detailed information concerning
the telemonitoring intervention.
Study variables
Initial assessment and baseline data
The following socio-demographic data will be collected
for every patient taking part in the study: health centre,
assigned GP and nurse, date of birth and age, gender, liv-
ing arrangements, main caregiver and relationship with
  R RA AN ND DO OM M   a as ss si ig gn nm me en nt t   o of f   p pa at ti ie en nt ts s   t to o   C CG G   o or r   I IG G   
 
x  Invite patients and families to participate in the study 
x  Request the collaboration of health care professionals 
 
N = 30 patients 
GC 
N = 30 patients 
GI 
PREPARATION AND TRAINING 
  4-hr WORKSHOP 
x  Management of COPD and HF and 
decompensation episodes 
x  Explanation of the project aims  
x  Utilisation of telemonitoring devices and 
Web-based platform (IG) 
SOFTWARE INSTALLATION, 
DEPLOYMENT OF DEVICES and TRAINING 
of health care professionals, patients and family members 
by the supplier and the research team 
FIRST VISIT, INITIAL 
ASSESSMENT & DATA 
COLLECTION 
Research Team 
  Informed consent 
  Socio-demographic and clinical data 
(baseline) 
PERIODIC VISITS (at 3, 6 and 12 
months) for ASSESSMENT AND 
DATA COLLECTION           
Research Team 
CLINICAL MANAGEMENT by 
DOCTORS (GP) & NURSES (N) 
 
  Daily check of the data received (GP,N) 
  Telephone call every two weeks (N) 
  Feedback by telephone (N, GP) 
  Action in the event of decompensation (GP, N) 
 
CLINICAL MANAGEMENT 
by DOCTORS & NURSES 
 
Usual care 
Figure 2 Key activities for the intervention (IG) and control (CG) groups and personnel involved in the study.
Figure 3 Telemonitoring kit used by patients in the
intervention group.
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adverse social factors (i.e.: poverty, social exclusion, lone-
liness, lack of support, isolation, recent widowhood).
The following clinical variables will also be recorded:
main disease (HF and/or CLD), degree of severity of the
disease (based on the FEV1 - forced expiratory volume
in one second- for COPD and on the NYHA - New
York Heart Association- classification and the ejection
fraction for HF. Severity of illness measures will be col-
lected at the moment of enrolment from the clinical
records depending on availability and will be used to
ensure comparability between the two groups), require-
ment for home oxygen therapy, name and list of the
drugs taken regularly, adherence to the prescribed medi-
cation (compliance) using the four-item self reported
scale proposed by Morinsky et al. [21], the Barthel
Index (BI) [22], the EuroQol questionnaire (EQ-5D)
[23-25], and the Zarit Burden Interview (ZBI) [26-28].
Outcome measures
All the outcome measures will be collected after 3, 6
and 12 months of follow-up, except for satisfaction with
the telemonitoring technology, which will be measured
only once (approximately after 3 months from the start
of the study). Table 2 shows a summary of the outcome
variables that will be evaluated in the present study.
1. Primary outcome measure Number of hospital
admissions due to any cause that occurred in a period of
12 months post-randomisation.
The hospitalizations will be classified as due to HF,
due to CLD (i.e., COPD, asthma and other respiratory
conditions) and non-cardiorespiratory causes.
2. Secondary outcome measures 2.1 Duration of hospi-
tal stay: number of bed-days for emergency admissions
with a primary diagnosis of HF, CLD (i.e., COPD,
asthma and other respiratory conditions) and other
causes during 12 months after randomisation.
2.2 Number of hospital admissions due to exacerbation of
HF and CLD (i.e., COPD, asthma and other respiratory con-
ditions)t h a to c c u r r e di nap e r i o do f1 2m o n t h sp o s t -
randomisation.
2.3 Mortality rate: number of all-cause deaths at
12 months. Cause of death will be taken from the pri-
mary and/or secondary care clinical records.
2.4 Level of use of health resources measured during a
period of 12 months after randomisation:
- Number of emergency department visits for a car-
diac or respiratory cause and for all causes.
- Number of home visits (by their GP or nurse).
- Number of primary care visits.
Figure 4 Web-platform accessed by health care professionals.
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care professionals.
- Number of visits to the specialist doctors.
2.5 Cost-effectiveness analysis. The costs associated
with the health care resources used will be estimated
based on the following variables: duration of hospital
stay, use of emergency services, purchase and mainte-
nance of telemonitoring devices, number of consulta-
tions and time of the health care personnel, as well as
the time dedicated by the health care professionals to
using the telemonitoring equipment. The effectiveness
will be expressed in Quality-Adjusted Life Years (QALY)
and will be calculated from the data of the Health
Related Quality of Life (HRQL) obtained from the gen-
eric EQ-5D questionnaire.
2.6 Health related quality of life (HRQL).T h ev a l i -
dated Spanish version of the EQ-5D questionnaire will
be employed for the quality of life assessment [23-25].
This questionnaire describes the health status in five
dimensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression) with three possible
responses for each item and using the visual analogue
scale (VAS) ranging between 0 and 100.
2.7 Other variables of clinical efficacy: number of epi-
sodes of worsening of the pulmonary and/or heart condi-
tion. An episode of worsening or exacerbation is defined
as a sustained worsening of the patient’ss y m p t o m sf r o ma
usual stable state that is beyond normal day-to-day varia-
tions and is acute in onset. Commonly reported symptoms
are oedema, breathlessness and nocturia for HF, and wor-
sening breathlessness, cough, increased sputum produc-
tion and change in sputum colour for CLD. An episode of
worsening is considered a change in these symptoms that
requires intervention or control by the physician.
2.8 Functional status. The Barthel Index (BI) [22] will
be used to measure Activities of Daily Living (ADL).
The score on the BI ranges between 0 and 100, with
results indicating: total dependence (0-20), severe
dependence (21-60), moderate dependence (61-90), little
dependence (91-99), and total independence (100).
2.9 Caregiver burden. The burden of the family/care-
giver will be measured using a validated Spanish version
of the Zarit Burden Interview (ZBI) [26-28]. The score
ranges from 0 (no burden) to 88 (highest level of burden).
2.10 Degree of acceptance and satisfaction of patients
and health professionals. The degree of satisfaction of
the patients with the telemonitoring intervention will be
Table 2 Summary of the outcome measures analysed in the study
Primary outcome measure Secondary outcome measures
Mortality - Mortality due to any cause
- Mortality due to HF or CLD
Use of health care resources - Hospital admissions due to any
cause
- Hospital admissions due to HF or CLD
- Duration of hospital stay
- Emergency department visits
- Home visits by GP or nurses
- Visits to primary care centres by family or caregivers
- Telephone contacts with professionals
- Visits to specialist doctors
Clinical efficacy - Worsening of the patients’ pulmonary and/or heart condition (number of
episodes)
Functional status and quality of
life
- Patient Quality of Life (EQ-5D questionnaire)
- Functional status (Barthel Index)
- Caregiver burden (Zarit Burden Interview)
Cost-effectiveness - Cost-effectiveness (using QALYs)
Satisfaction with the new
technology
- Degree of satisfaction of patients and health care professionals
Compliance - Patient and provider compliance with the telemonitoring
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lished surveys adapted for this study [29-31]. It consists
of 18 items grouped in eight dimensions. The patient
satisfaction questionnaires will be administered at the
patient’s home by an independent female sociologist not
involved in the care process. The degree of satisfaction
of GPs and nurses participating in the intervention
group will be assessed through a qualitative study based
on focus group methodology and by means of a specific
questionnaire designed ad hoc. A Web-based version of
the questionnaire for health care professionals will be
delivered electronically.
2.11 Evaluation of the technical performance and com-
pliance with the telemonitoring system.
Compliance with telemonitoring will be evaluated
through the analysis of the frequency of data trans-
mitted by patients and the number of times that health
care professionals access the telemonitoring Web-plat-
form. Additionally, the reliability and performance of
the telemonitoring system will be assessed (malfunctions
of the system, problems concerning the transfer, recep-
tion and visualisation of data). The security of the sys-
tem will also be evaluated (external attacks to the
transmission system or server, etc.).
The reasons for the losses occurred during the study will
be recorded. It is envisaged that such losses may include
patients moving house or dying, failure to correctly man-
age the system, technical problems, requirements for spe-
cific health care (for example, patients in need of palliative
care at home) and institutionalisation. Additionally, data
concerning eligible patients or professionals who declined
to participate in the study and the reasons for not partici-
pating in the study will be recorded.
Sample size
Thirty patients will be recruited in each of the study
groups, the main constraints being the number of avail-
able devices and the number of potential patients fulfill-
ing the inclusion criteria in the Bilbao Primary Care
Health Region. Thus, if 30 patients are included in each
group, and a 10% loss to follow-up is assumed at 12
months (based on previous analysis of mortality and
other causes of loss in patients with similar characteris-
tics), we have estimated a statistical power of 72% to
detect significant differences between the CG and the
IG in the mean number of total admissions with a level
of significance of 5%. For the power calculation, it has
been assumed that the mean number of admissions in
the CG is 3.5, the standard deviation 1.7, and there will
be a 35% decrease of hospitalisations in the IG with
respect to the CG [32-34]. The power calculations have
been performed with the sample size calculation soft-
ware Ene 2.0.
Statistical Analysis
The download, processing and statistical analysis of the
data collected during the study will be performed using
PASW Statistics 18 software (SPSS). The researchers in
charge of the statistical analysis will be blinded to the
assignment of the patients to the IG or CG.
Description of the baseline characteristics of the patients
The unit of the study is the patient. The following statis-
tics will be used for the descriptive analysis: mean, stan-
dard deviation, median and rank for the quantitative
variables, and frequency and percentage for the qualitative
variables. Socio-demographic and baseline clinical data
will be compared between the two groups in order to test
the homogeneity. Losses occurring during the study will
be analysed and the main baseline characteristics of drop-
outs will be compared to those who have completed the
study. For the comparison of quantitative variables, the
Student’s t-test and the non-parametric Mann Whitney U
test will be used for normally and non-normally distribu-
ted data, respectively. The Chi-square or the Fisher’s exact
tests will be used for the comparison of qualitative vari-
ables. The level of statistical significance will be set at
p<0 . 0 5 .
Analysis of the main outcome measure and impact on the
use of the health care services
Firstly, at 3, 6 and 12 months follow-up, a descriptive
analysis of the primary and secondary outcome measures
will be carried out in the two study groups (number of
hospital admissions, duration of the hospital stay and
mortality rate). The variables related to the use of health
care services, clinical efficacy, functional status of the
patients (BI), the health related quality of life -HRQL-
(EQ-5D) and the family/caregiver burden (ZBI) will also
be analysed. Additionally, given that certain variables will
have different follow-up periods, the incidence-rates of
certain variables, such as mortality, hospital admissions,
visits and episodes of worsening will be calculated.
Subsequently, both primary and secondary outcome
measures will be compared between the two groups of
patients at each follow-up point to test whether signifi-
cant differences exist. Any changes in the functional
condition (BI) or HRQL of the patients (EQ-5D) and
caregiver burden (ZBI) with respect to the baseline
levels will also be assessed at 3, 6 and 12 months (i.e.,
difference between the follow-up and initial scores).
Quantitative variables will be compared using the Stu-
dent t-test or the non-parametric Mann Whitney U test,
while qualitative variables will be assessed using the
Chi-Square or Fisher’s exact tests. The Student’sp a i r e d
t-test will be used to compare the differences between
t h eb a s e l i n es c o r e so nt h eB I ,t h eE Q - 5 Da n dt h eZ B I
and the scores obtained at 3, 6 and 12 months follow-
up, for each group of patients.
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between the CG and the IG for the baseline characteristics
analysed, the comparisons of the main outcome measures
will be adjusted by the corresponding baseline variables. A
logistic regression model will be used to compare dichoto-
mous categorical variables (such as, mortality), while a
general linear model will be used for quantitative variables
(such as, the duration of hospital stay). In the latter case,
the dependant variable will be appropriately transformed if
it does not fit the normal distribution. Finally, multilevel
analysis will be performed to test the effect of the indivi-
dual primary care professionals involved and the clinical
practice site on the results.
Whenever possible, the number needed to treat
(NNT) will be calculated for the primary outcome vari-
able (number of hospital admissions).
Economic analysis of the telemonitoring intervention
A cost-effectiveness analysis will be undertaken from the
perspective of the health care provider. The time hori-
zon will be of one year.
Assessment of the effectiveness The QALYs, calculated
from the EQ-5D questionnaire results, will be used as a
measure of effectiveness. The QALYs will be estimated by
calculating the area under the curve (AUC), which is
obtained by summing up the areas of the geometrical
shapes obtained by linear interpolation between the utility
scores during the study period [35]. In addition, the base-
line utility will be controlled using a regression-based
adjustment, since there tends to be a strong correlation
between the baseline utility of patients and the QALY
scores [35].
Cost assessment Only direct unit costs per patient will be
calculated. Indirect (caregivers, etc.) and intangible costs
will not be considered for the analysis. The specific costs
that will be taken into account include: costs directly asso-
ciated with the telemonitoring intervention (cost of pur-
chase and maintenance of the system, training of
professionals in the use of the system, salaries of the health
care professionals), costs associated with the home care
(visits and telephone calls), costs related to the impact of
the telemonitoring program on the necessary resources for
the provision of patient care (number of visits to a primary
care doctor, visit to the emergency department, number of
hospital admissions). The costs will be based on 2009
figures and will be expressed in euros.
Health resources use estimates will be measured con-
sidering the following variables: number of telephone
consultations (both control calls and calls made as a
result of alerts) made or received by health care profes-
sionals (by the GP or nurse), average duration of tele-
phone consultations, number of home care visits (both
control visits and visits due to alerts) performed by health
care professionals (by the general practitioner or nurse),
average time spent by health care professionals to check
the telemonitoring data daily, number of primary care
visit, number of emergency department visits, number of
visits to the specialist doctors and number of hospital
admissions. The time taken to check telemonitoring data
daily or undertaken monitoring telephone calls will be
estimated by timing a sample of these tasks.
Resource use estimates will be combined with unit
costs per patient obtained as follows: the time spent by
health care professionals in made and answered tele-
phone consultations and in checking the telemonitoring
data daily, will be assessed based on the salaries for
nurses and GPs as reflected in the Basque Health Ser-
vice wage payment tables; primary care visits, emergency
department visits and visits to the specialist doctors, will
be amounted in accordance with the Osakidetza billing
rates for health care services; hospital admissions will be
assessed according to Diagnostic Related Groups
(DRGs) for each pathologic condition; telemonitoring
equipment (software and devices) will be assessed based
on their equivalent annual cost, maintenance and train-
ing for their management will be valued using the mar-
ket price provided by the supplier.
The cost of telecommunications and computer equip-
ment will not be considered, since this is an already
implemented infrastructure in the Basque Health Sys-
tem, which is used for many other applications and
daily tasks in addition to the telemonitoring process.
The cost per patient will be minimal and, therefore,
ignored in the costs calculation.
As the comparison is restricted to the programs under
study, costs common to both need not be considered as
they will not affect the choice between the given
programs.
The costs will be based on 2009 figures and will be
expressed in euros. The discount-rate used to calculate
the equivalent annual cost will be 3%.
Presentation of the economic analysis Once the QALY
scores and the costs associated with the two care
options under study have been estimated, the incremen-
tal cost-effectiveness ratio (ICER) will be calculated to
determine which approach is most effective in terms of
QALYs. To determine the degree of uncertainty, a sensi-
tivity analysis will be carried out using the non-para-
metric bootstrapping method [36].
The ICER values estimated using bootstrapping re-
sampling, together with the resulting distribution, will
be used to estimate the 95% confidence intervals and
will be plotted on a cost-effectiveness plane, to deter-
mine the quadrant in which the procedure under study
lies (dominated, dominant, more costly and more effec-
tive or less costly and less effective). The cost-effective
ICER proportions that lie, under the threshold widely
accepted in Spain (30,000€/QALY) will be plotted using
acceptance curves.
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procedure
The validity and reliability of the patient satisfaction
questionnaire will be analysed. A panel of experts in
Health Technology Assessment will evaluate the face and
content validity of the instrument. Cronbach alpha will
be calculated to measure the reliability of each scale. An
exploratory factor analysis will be conducted to deter-
mine the construct validity. Convergent and divergent
validity of the items will be assessed by determining the
correlation between each item and the factors.
The scales corresponding to each of the domains of the
questionnaire will be calculated by summing up the
responses obtained for all items on that scale and will be
standardised on a 0 to 100 scale. Given the absence of a
gold standard, the criterion-related validity will be stu-
died by determining whether the patients reporting lower
levels of satisfaction correlate with higher mortality rates,
longer hospital stays, higher number of hospital admis-
sions, higher use of health care resources and more epi-
sodes of worsening. In addition, the scales of the
questionnaire will be compared by socio-demographic
and baseline clinical characteristics. The Student t-test or
the analysis of variance will be used for normally distrib-
uted data, and the Mann Whitney U test or the Kruskal-
Wallis test for non-normally distributed data.
Analysis of the technical performance and compliance with
the telemonitoring system
Data concerning patient and health care professional
compliance with telemonitoring, as well as the reliability,
performance and security of the telemonitoring proce-
dure over the course of the study will be described.
Ethics approval
T h es t u d yw a sa p p r o v e db yt h eE t h i c sC o m m i t t e ef o r
Scientific Research (CEIC, Basurto Hospital, Bizkaia) on
the 16
th of December 2009. Patients or relatives gave writ-
ten informed consent prior to participating in the study.
Study limitations
D u et ot h ei n t e r a c t i v en a t u r eo ft h ei n t e r v e n t i o n ,i ti s
not possible to blind the health care professionals pro-
viding the intervention or the participants involved in
the study. Despite the aforementioned limitation, most
of the key data are objective and will be obtained from
medical registers (hospital admissions, use of health care
resources, etc.). Methods have been put in place to dou-
ble-check the veracity of the data obtained. Moreover,
the statisticians in charge of the data analysis will be
blinded to group assignment.
The number of patients included in the present study
is limited by the available telemonitoring devices.
Despite recruitment of a higher number of patients
would have been desirable, we have estimated a power
of 72% to detect significant differences in the main out-
come measure between the two study groups.
Discussion
The results of this study will shed some light on the effects
of telemonitoring for the follow-up and management of
chronic patients from a primary care setting. The present
investigation will provide data on the clinical efficacy,
patient’s quality of life and health services costs. The level
of acceptance, obstacles and facilitating factors for the use
of the new telemonitoring technology will also be
explored. Improving the medical support provided to
elderly chronic patients and their family/caregivers has the
potential to decrease health service usage and increase
their quality of life through improved worsening symptom
identification and a better continuity of care.
Among the main contributions of the present study
we could highlight the following:
1. The telemonitoring intervention will be controlled
and managed by the primary health care professionals
(GPs and nurses) who routinely see the patients in the
health centres. This is a realistic approach that inte-
grates a new health care strategy within the primary
health care sector. The study involves all the primary
health centres in the Bilbao Health Region and, there-
fore, the application of ICTs to the management of
chronic patients may have a significant impact on the
internal organisation of an entire Health Region.
2. The subgroup of patients selected for the study
suffers from two of the most commonly targeted dis-
eases for home telecare interventions (i.e., HF and
CLD). In addition, the patients included in the present
study show certain added peculiarities: they are home
care patients with frequent hospital admissions and
with a higher mean age than that targeted by most
other published studies. Therefore, the study may con-
tribute to enhance the understanding of alternative
modes of health care provision for medically unstable
patients with a high degree of physical and functional
deterioration.
3. The present study will also evaluate the acceptance
of the new technology by health care professionals and
patients/caregivers which could be critical for the adop-
tion of ICTs in the health care sector. In particular, we
would like to point out the considerable number of
health care professionals that will be involved in the
study, which could provide substantial data to thoroughly
assess provider satisfaction with telemonitoring technol-
ogy by means of qualitative and quantitative methods.
4. The study could provide evidence to determine the
feasibility of the use of ICT applications by elderly
patients with limited computer literacy.
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